These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 28644215)

  • 21. Longitudinal Stent Deformation: Precise Diagnosis With Optical Coherence Tomography.
    Hernández-Matamoros H; Gonzálvez-Garcia A; Moreno-Gómez R; Jiménez-Valero S
    J Invasive Cardiol; 2019 Dec; 31(12):E395. PubMed ID: 31786534
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Twenty-four months of follow-up of a "biodegradable" model for coronary artery bifurcation management. Insights from optical coherence tomography of a new interventional strategy.
    Buccheri D; Cortese B
    Int J Cardiol; 2016 Nov; 222():37-38. PubMed ID: 27448703
    [No Abstract]   [Full Text] [Related]  

  • 23. In-stent restenosis nine years after initial placement of a drug-eluting stent.
    Hopkinson DA; Raje V; Jovin IS
    Cardiovasc Revasc Med; 2018 Jan; 19(1 Pt A):26-28. PubMed ID: 28546034
    [TBL] [Abstract][Full Text] [Related]  

  • 24. First-in-man demonstration of complete bioresorbable vascular scaffold resorption after treatment of in-stent restenosis.
    Moscarella E; Ielasi A; Cortese B; De Angelis MC; Varricchio A
    Coron Artery Dis; 2017 Aug; 28(5):437-439. PubMed ID: 28574901
    [No Abstract]   [Full Text] [Related]  

  • 25. Drug-coated balloon for recurrent in-stent restenosis treatment: A suitable strategy.
    Piraino D; Buccheri D; Cimino G; Andolina G
    Int J Cardiol; 2016 Oct; 221():1084-6. PubMed ID: 27448537
    [No Abstract]   [Full Text] [Related]  

  • 26. A next-generation bioresorbable coronary scaffold system: from bench to first clinical evaluation: 6- and 12-month clinical and multimodality imaging results.
    Verheye S; Ormiston JA; Stewart J; Webster M; Sanidas E; Costa R; Costa JR; Chamie D; Abizaid AS; Pinto I; Morrison L; Toyloy S; Bhat V; Yan J; Abizaid A
    JACC Cardiovasc Interv; 2014 Jan; 7(1):89-99. PubMed ID: 24139932
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of morphologic characteristics on optical coherence tomography and angiographic progression patterns of late restenosis after drug-eluting stent implantation.
    Yamaguchi H; Arikawa R; Takaoka J; Miyamura A; Atsuchi N; Ninomiya T; Atsuchi Y; Ohishi M; Terashima M; Kaneda H
    Cardiovasc Revasc Med; 2015; 16(1):32-5. PubMed ID: 25617940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In-stent accordion phenomenon.
    Nishi T; Hasegawa A; Miyahara H; Nameki M; Kobayashi Y
    Int J Cardiol; 2016 Oct; 220():129-30. PubMed ID: 27376568
    [No Abstract]   [Full Text] [Related]  

  • 29. Very Late Restenosis Following Bioresorbable Scaffold Implantation.
    Okuno T; Yahagi K; Horiuchi Y; Aoki J; Simonton CA; Rapoza R; Saito S; Kimura T; Tanabe K
    JACC Cardiovasc Interv; 2017 Sep; 10(18):e167-e169. PubMed ID: 28866033
    [No Abstract]   [Full Text] [Related]  

  • 30. Use of a bioresorbable novolimus eluting vascular scaffold fails a hybrid PCI strategy with drug eluting stent.
    Schneider VS; Skurk C; Riedel M; Abdelwahed YS; Landmesser U; Leistner DM
    Clin Res Cardiol; 2017 Jul; 106(7):557-559. PubMed ID: 28374059
    [No Abstract]   [Full Text] [Related]  

  • 31. In-stent restenosis because of nickel hypersensitivity: a bioresorbable solution?
    Granata F; Moscarella E; Varricchio A
    Coron Artery Dis; 2015 Aug; 26(5):461-2. PubMed ID: 25816019
    [No Abstract]   [Full Text] [Related]  

  • 32. Successful use of bioresorbable vascular scaffold in in-stent restenosis previously exposed to vascular brachytherapy.
    Wong KL; Fan KY; Jim MH
    Int J Cardiol; 2015 Feb; 181():1-2. PubMed ID: 25473779
    [No Abstract]   [Full Text] [Related]  

  • 33. Restenosis After Everolimus-eluting Vascular Scaffolding. Angiographic and Optical Coherence Tomography Characterization.
    Chavarría J; Suárez de Lezo J; Ojeda S; Pan M; Segura J; Mazuelos F; Espejo S; López J; Romero M; Suárez de Lezo J
    Rev Esp Cardiol (Engl Ed); 2017 Jul; 70(7):543-550. PubMed ID: 28132761
    [TBL] [Abstract][Full Text] [Related]  

  • 34. First reported use of drug-coated balloon for bioresorbable in-scaffold restenosis.
    Latini RA; Buccheri D; Cortese B
    Catheter Cardiovasc Interv; 2017 Mar; 89(4):676-678. PubMed ID: 27649683
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bioabsorbable drug-eluting vascular scaffold for the treatment of coronary in-stent restenosis: A two center registry.
    Moscarella E; Varricchio A; Stabile E; Franzone A; Granata F; Rapacciuolo A; Galasso G; Capozzolo C; Cirillo P; Monda V; Monterforte I; Borgia F; Piro O; Bonzani G; Trimarco B; Esposito G
    Cardiovasc Revasc Med; 2015; 16(7):401-5. PubMed ID: 26342404
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atypical "vacuum" inside of neoatherosclerosis long term after DES implantation: insights from optical coherence tomography.
    Granata F; Attizzani GF; Tartaglione D; Cappelli Bigazzi M; Bianchi R; Varricchio A; Russo MG; Calabrò P
    Int J Cardiol; 2015 Nov; 199():221-2. PubMed ID: 26209822
    [No Abstract]   [Full Text] [Related]  

  • 37. Unusually aggressive immature neo-intimal hyperplasia causing in-stent restenosis.
    McCutcheon K; Triantafyllis AS; Bennett J; Adriaenssens T
    Cardiovasc J Afr; 2017 Nov/Dec 23; 28(6):404-405. PubMed ID: 29019519
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Feasibility of use of magnesium reabsorbable scaffolds in complex coronary artery disease: True bifurcation, multiple overlapping scaffolds and chronic total occlusion treatment.
    Bayón J; Santá-Álvarez M; Ocaranza-Sánchez R; González-Juanatey C
    Rev Port Cardiol (Engl Ed); 2018 Dec; 37(12):1009.e1-1009.e3. PubMed ID: 30554888
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of Early Healing Profile and Neointimal Transformation Over 24 Months Using Longitudinal Sequential Optical Coherence Tomography Assessments and 3-Year Clinical Results of the New Dual-Therapy Endothelial Progenitor Cell Capturing Sirolimus-Eluting Combo Stent: The EGO-Combo Study.
    Lee SW; Lam SC; Tam FC; Chan KK; Shea CP; Kong SL; Wong AY; Yung A; Zhang LW; Tse HF; Wu KK; Chan R; Haude M; Mehran R; Mintz GS; Maehara A
    Circ Cardiovasc Interv; 2016 Jul; 9(7):. PubMed ID: 27418609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stent fracture and thrombosis visualized by a combination of enhanced stent visualization and optical coherence tomography.
    Oba Y; Funayama H; Takahashi M; Kario K
    Coron Artery Dis; 2020 Nov; 31(7):660. PubMed ID: 32097131
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.